3 most recent filings and news items mentioning RXST. Updated every 60 seconds.
GuidanceAug 5, 2026Neutral
RxSight reported Q2 revenue of $33.7 million with a strategic Alcon collaboration of $6.5 million and withdrew 2026 guidance to focus on business review and commercial execution.
View filing at SEC.gov →
LeadershipJul 15, 2026Neutral
RxSight appointed Aziz Mottiwala as Chief Executive Officer, succeeding Ron Kurtz, M.D. The leadership transition includes Dr. Kurtz resigning from the Board to focus on his role as Chief Medical Officer.
View filing at SEC.gov →
M&AJul 6, 2026Positive
RxSight and Alcon announced a collaboration to jointly develop adjustable intraocular lenses. The deal includes an upfront payment and potential milestone payments for RxSight.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.